Clinical trials
Phase 1/2 Diabetes Mellitus trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Terminated | 8 |
| Withdrawn | 5 |
| Recruiting | 4 |
| Active, not recruiting | 4 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Colorado, Denver | 3 |
| Joshua M Hare | 2 |
| Mayo Clinic | 2 |
| National Center for Complementary and Integrative Health (NCCIH) | 2 |
| National Eye Institute (NEI) | 2 |
| University of Minnesota | 2 |
| ARKAY Therapeutics | 1 |
| Admetsys Corporation | 1 |
| Altea Therapeutics | 1 |
| AsclepiX Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 57 |
| Diabetes Mellitus, Type 1 | 16 |
| Diabetes Mellitus, Type 2 | 11 |
| Hypoglycemia | 7 |
| Hyperglycemia | 5 |
| Diabetic Retinopathy | 4 |
| Obesity | 4 |
| Diabetic Nephropathies | 3 |
| Endocrine System Diseases | 3 |
| Insulin Resistance | 3 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.